CoChat
Sign Up
Cited by 115

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Reduced Mature MicroRNA Levels in Association with Dicer Loss in Human Temporal Lobe Epilepsy with Hippocampal Sclerosis

McKiernan, Ross C., Jimenez-Mateos, Eva M., Bray, Isabella, Engel, Tobias, Brennan, Gary P., Sano, Takanori, Michalak, Zuzanna, Moran, Catherine, Delanty, Norman, Farrell, Michael, O’Brien, Donncha, Meller, Robert, Simon, Roger P., Stallings, Raymond L., Henshall, David C.·2012·PLoS ONE
DOI 10.1371/journal.pone.0035921PMC PMC3352899
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0035921

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Reduced Dicer levels in TLE patients with hippocampal sclerosis. (A) Representative histology for autopsy controls and patient samples. (a) Photomicrograph showing field view of a cresyl violet-stained section from an autopsy control hippocampus (C2). (b) Photomicrograph showing a field view of the hippocampus from a TLE-HS patient (E2). Boxes in b indicate regions of the section from which higher-power images and other stains in c–e are presented. (c) Evident pyramidal neuron loss in the CA1 sector (20× lens). (d) Granule cell layer dispersion in E2. (e) GFAP immunohistochemistry showing astrogliosis within the granule cell layer. (f, g) Cresyl violet and GFAP-stained sections from patient E3 showing granule cell layer dispersion and astrogliosis (20× lens). Scale bar in a, b, 1 mm; c–g, 100 µm. (B) Representative Western blots showing protein levels of neuron (NeuN) and astrocyte (GFAP) markers in hippocampus from controls (C1–4) and TLE-HS patients (E1–4). (C) Semi-quantification of protein levels (n = 4 per group). Levels of the uppermost band (∼66 kD) and a lower band (48 kD) were lower in TLE-HS samples, whereas GFAP (uppermost band analyzed) was higher. (D, E) Representative Western blots and graphs showing protein levels and semi-quantification for Dicer, Drosha and AGO2. *p<0.05; **p<0.01 compared to controls. Protein levels corrected to α-Tubulin (α-Tub).
Figure 1 Reduced Dicer levels in TLE patients with hippocampal sclerosis. (A) Representative histology for autopsy controls and patient samples. (a) Photomicrograph showing field view of a cresyl violet-stained section from an autopsy control hippocampus (C2). (b) Photomicrograph showing a field view of the hippocampus from a TLE-HS patient (E2). Boxes in b indicate regions of the section from which higher-power images and other stains in c–e are presented. (c) Evident pyramidal neuron loss in the CA1 sector (20× lens). (d) Granule cell layer dispersion in E2. (e) GFAP immunohistochemistry showing astrogliosis within the granule cell layer. (f, g) Cresyl violet and GFAP-stained sections from patient E3 showing granule cell layer dispersion and astrogliosis (20× lens). Scale bar in a, b, 1 mm; c–g, 100 µm. (B) Representative Western blots showing protein levels of neuron (NeuN) and astrocyte (GFAP) markers in hippocampus from controls (C1–4) and TLE-HS patients (E1–4). (C) Semi-quantification of protein levels (n = 4 per group). Levels of the uppermost band (∼66 kD) and a lower band (48 kD) were lower in TLE-HS samples, whereas GFAP (uppermost band analyzed) was higher. (D, E) Representative Western blots and graphs showing protein levels and semi-quantification for Dicer, Drosha and AGO2. *p<0.05; **p<0.01 compared to controls. Protein levels corrected to α-Tubulin (α-Tub).CC BY · PubMed Central
Figure 2 Reduced mature miRNA expression in human TLE-HS. (A) Heat-map depiction of raw miRNA expression data for 188 of the expressed miRNAs from controls (C1–C4) and TLE-HS samples (TLE1, TLE2 and TLE4). Note the reduction in miRNA levels (green bars) in TLE-HS samples. Scale bar to left indicates fold differences. (B) Pie chart summarizing the findings from profiling miRNA levels in human TLE-HS samples. Over half the expressed miRNAs were found to be lower than in controls. (C) Graph showing the expression of the significantly down-regulated miRNAs in TLE-HS samples. Individual Ct values from each TLE sample were normalized to the average of the Ct values from the control group. The graph represents the average of the 2−ΔΔCt of each TLE sample. *p<0.05; **p<0.01; ***p<0.001 compared to control (from n = 4 controls versus n = 3 TLE-HS samples). Note, Hsa is nomenclature denoting human miRNA sequence. (D) Graphs (n = 3–4 per group) showing expression (2−ΔΔCt, normalized to Gapdh) for a selection of pri-miRNAs in the same control and TLE-HS samples.
Figure 2 Reduced mature miRNA expression in human TLE-HS. (A) Heat-map depiction of raw miRNA expression data for 188 of the expressed miRNAs from controls (C1–C4) and TLE-HS samples (TLE1, TLE2 and TLE4). Note the reduction in miRNA levels (green bars) in TLE-HS samples. Scale bar to left indicates fold differences. (B) Pie chart summarizing the findings from profiling miRNA levels in human TLE-HS samples. Over half the expressed miRNAs were found to be lower than in controls. (C) Graph showing the expression of the significantly down-regulated miRNAs in TLE-HS samples. Individual Ct values from each TLE sample were normalized to the average of the Ct values from the control group. The graph represents the average of the 2−ΔΔCt of each TLE sample. *p<0.05; **p<0.01; ***p<0.001 compared to control (from n = 4 controls versus n = 3 TLE-HS samples). Note, Hsa is nomenclature denoting human miRNA sequence. (D) Graphs (n = 3–4 per group) showing expression (2−ΔΔCt, normalized to Gapdh) for a selection of pri-miRNAs in the same control and TLE-HS samples.CC BY · PubMed Central
Figure 3 miRNA biogenesis components in neocortex and in experimental epilepsy. (A) Representative Western blots showing expression of Dicer, Drosha and AGO2 in neocortex samples from TLE patients (TLE 9–11) and controls (C3–C5). (B) Graphs (n = 3 per group) showing semi-quantification of levels of each protein. **p<0.05 compared to controls. Protein levels corrected to α-Tubulin (α-Tub). (C) Representative immunohistochemistry illustrating the hippocampal damage in epileptic mice. (a) Field view (4× lens) showing triple-stained section from an epileptic mouse 21 days after status epilepticus. Box highlights main lesion area in CA3. b,c are 20× lens field views of the lesioned CA3 area showing reduced NeuN (red) and increased GFAP (green) staining. (D) Representative views of the CA3 from a control mouse at 21 days which did not undergo status epilepticus. a–c show NeuN (red), GFAP (green) and a merge of these with DAPI overlay. Note the intact neuron population and minimal GFAP staining. Scale bar in Ca, 500 µm; Cb, and Da, 100 µm. (E, F) Representative Western blots (n = 1 per lane) showing protein levels of NeuN, GFAP, Dicer, Drosha and Ago2 in CA3 samples from control and epileptic (21 day) mice (TLE-HS). (G) Graph quantifying reduction in hippocampal CA3 Dicer levels in epileptic animals (n = 7–8 per group; *p<0.05 compared to control). Protein levels corrected to α-Tub. (H) Representative Western blots (n = 1 per lane) show non-damaging seizures do not cause a reduction of Dicer levels. α-Tubulin is included as a guide to protein loading.
Figure 3 miRNA biogenesis components in neocortex and in experimental epilepsy. (A) Representative Western blots showing expression of Dicer, Drosha and AGO2 in neocortex samples from TLE patients (TLE 9–11) and controls (C3–C5). (B) Graphs (n = 3 per group) showing semi-quantification of levels of each protein. **p<0.05 compared to controls. Protein levels corrected to α-Tubulin (α-Tub). (C) Representative immunohistochemistry illustrating the hippocampal damage in epileptic mice. (a) Field view (4× lens) showing triple-stained section from an epileptic mouse 21 days after status epilepticus. Box highlights main lesion area in CA3. b,c are 20× lens field views of the lesioned CA3 area showing reduced NeuN (red) and increased GFAP (green) staining. (D) Representative views of the CA3 from a control mouse at 21 days which did not undergo status epilepticus. a–c show NeuN (red), GFAP (green) and a merge of these with DAPI overlay. Note the intact neuron population and minimal GFAP staining. Scale bar in Ca, 500 µm; Cb, and Da, 100 µm. (E, F) Representative Western blots (n = 1 per lane) showing protein levels of NeuN, GFAP, Dicer, Drosha and Ago2 in CA3 samples from control and epileptic (21 day) mice (TLE-HS). (G) Graph quantifying reduction in hippocampal CA3 Dicer levels in epileptic animals (n = 7–8 per group; *p<0.05 compared to control). Protein levels corrected to α-Tub. (H) Representative Western blots (n = 1 per lane) show non-damaging seizures do not cause a reduction of Dicer levels. α-Tubulin is included as a guide to protein loading.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 49

  1. DP Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function., Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  2. Y Lee, 2003, The nuclear RNase III Drosha initiates microRNA processing., Nature, 425, 415, 10.1038/nature01957 · DOI
  3. VN Kim, 2009, Biogenesis of small RNAs in animals., Nat Rev Mol Cell Biol, 10, 126, 10.1038/nrm2632 · DOI · Paper page
  4. M Coolen, 2009, MicroRNAs in brain development and physiology., Curr Opin Neurobiol, 19, 461, 10.1016/j.conb.2009.09.006 · DOI
  5. A Schaefer, 2007, Cerebellar neurodegeneration in the absence of microRNAs., J Exp Med, 204, 1553, 10.1084/jem.20070823 · DOI · Paper page
  6. TH Davis, 2008, Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus., J Neurosci, 28, 4322, 10.1523/JNEUROSCI.4815-07.2008 · DOI · Paper page
  7. W Konopka, 2010, MicroRNA loss enhances learning and memory in mice., J Neurosci, 30, 14835, 10.1523/JNEUROSCI.3030-10.2010 · DOI · Paper page
  8. J Tao, 2011, Deletion of astroglial dicer causes non-cell-autonomous neuronal dysfunction and degeneration., J Neurosci, 31, 8306, 10.1523/JNEUROSCI.0567-11.2011 · DOI
  9. J Bilen, 2006, MicroRNA pathways modulate polyglutamine-induced neurodegeneration., Mol Cell, 24, 157, 10.1016/j.molcel.2006.07.030 · DOI
  10. S Haramati, 2010, miRNA malfunction causes spinal motor neuron disease., Proc Natl Acad Sci USA, 107, 13111, 10.1073/pnas.1006151107 · DOI
  11. SS Hebert, 2010, Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration., Hum Mol Genet, 19, 3959, 10.1093/hmg/ddq311 · DOI
  12. BS Chang, 2003, Epilepsy., N Engl J Med, 349, 1257, 10.1056/NEJMra022308 · DOI
  13. M Thom, 2009, Hippocampal sclerosis: progress since Sommer., Brain Pathol, 19, 565, 10.1111/j.1750-3639.2008.00201.x · DOI
  14. S Bothwell, 2001, Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy., J Neurosci, 21, 4789, 10.1523/JNEUROSCI.21-13-04789.2001 · DOI
  15. S Dawodu, 2005, Quantitative neuropathology of the entorhinal cortex region in patients with hippocampal sclerosis and temporal lobe epilepsy., Epilepsia, 46, 23, 10.1111/j.0013-9580.2005.21804.x · DOI
  16. A Pitkanen, 2011, Mechanisms of epileptogenesis and potential treatment targets., Lancet Neurol, 10, 173, 10.1016/S1474-4422(10)70310-0 · DOI
  17. A Vezzani, 2011, The role of inflammation in epilepsy., Nat Rev Neurol, 7, 31, 10.1038/nrneurol.2010.178 · DOI · Paper page
  18. Y Bozzi, 2011, Cell signaling underlying epileptic behavior., Front Behav Neurosci, 5, 45, 10.3389/fnbeh.2011.00045 · DOI
  19. EM Jimenez-Mateos, 2011, MicroRNA expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132., Am J Pathol, 179, 2519, 10.1016/j.ajpath.2011.07.036 · DOI
  20. G Mouri, 2008, Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice., Brain Res, 1213, 140, 10.1016/j.brainres.2008.03.061 · DOI · Paper page
  21. EM Jimenez-Mateos, 2010, Epileptic tolerance is associated with enduring neuroprotection and uncoupling of the relationship between CA3 damage, neuropeptide Y rearrangement and spontaneous seizures following intra-amygdala kainic acid-induced status epilepticus in mice., Neuroscience, 171, 556, 10.1016/j.neuroscience.2010.09.003 · DOI
  22. H Kaneko, 2011, DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration., Nature, 471, 325, 10.1038/nature09830 · DOI · Paper page
  23. E Aronica, 2010, Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy., Eur J Neurosci, 31, 1100, 10.1111/j.1460-9568.2010.07122.x · DOI · Paper page
  24. AS Nudelman, 2010, Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo., Hippocampus, 20, 492
  25. YJ Song, 2011, Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b., Brain Res, 1387, 134, 10.1016/j.brainres.2011.02.073 · DOI · Paper page
  26. ST Lee, 2011, Altered microRNA regulation in Huntington’s disease models., Exp Neurol, 227, 172, 10.1016/j.expneurol.2010.10.012 · DOI · Paper page
  27. G Lugli, 2005, Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner., J Neurochem, 94, 896, 10.1111/j.1471-4159.2005.03224.x · DOI · Paper page
  28. MM Ghodgaonkar, 2009, Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1., Cell Death Differ, 16, 858, 10.1038/cdd.2009.15 · DOI
  29. A Nakagawa, 2010, Caspase-dependent conversion of Dicer ribonuclease into a death-promoting deoxyribonuclease., Science, 328, 327, 10.1126/science.1182374 · DOI
  30. DC Henshall, 2000, Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy., Neurology, 55, 250, 10.1212/WNL.55.2.250 · DOI
  31. DC Henshall, 2004, Death-associated protein kinase expression in human temporal lobe epilepsy., Ann Neurol, 55, 485, 10.1002/ana.20001 · DOI
  32. S Cheloufi, 2010, A dicer-independent miRNA biogenesis pathway that requires Ago catalysis., Nature, 465, 584, 10.1038/nature09092 · DOI · Paper page
  33. D Cifuentes, 2010, A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity., Science, 328, 1694, 10.1126/science.1190809 · DOI
  34. NY Shao, 2010, Comprehensive survey of human brain microRNA by deep sequencing., BMC Genomics, 11, 409, 10.1186/1471-2164-11-409 · DOI · Paper page
  35. E Mor, 2011, Species-specific microRNA roles elucidated following astrocyte activation., Nucleic Acids Res, 39, 3710, 10.1093/nar/gkq1325 · DOI
  36. TP Chendrimada, 2005, TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing., Nature, 436, 740, 10.1038/nature03868 · DOI
  37. D Shin, 2009, Dicer ablation in oligodendrocytes provokes neuronal impairment in mice., Ann Neurol, 66, 843, 10.1002/ana.21927 · DOI
  38. RI Gregory, 2004, The Microprocessor complex mediates the genesis of microRNAs., Nature, 432, 235, 10.1038/nature03120 · DOI
  39. KL Stark, 2008, Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model., Nat Genet, 40, 751, 10.1038/ng.138 · DOI · Paper page
  40. E Koscianska, 2011, The role of Dicer protein partners in the processing of microRNA precursors., PLoS One, 6, e28548, 10.1371/journal.pone.0028548 · DOI
  41. R Fiore, 2009, Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels., EMBO J, 28, 697, 10.1038/emboj.2009.10 · DOI · Paper page
  42. J Wetherington, 2008, Astrocytes in the epileptic brain., Neuron, 58, 168, 10.1016/j.neuron.2008.04.002 · DOI
  43. A Yamamoto, 2006, Endoplasmic reticulum stress and apoptosis signaling in human temporal lobe epilepsy., J Neuropathol Exp Neurol, 65, 217, 10.1097/01.jnen.0000202886.22082.2a · DOI
  44. TZ Baram, 2011, Does acquired epileptogenesis in the immature brain require neuronal death., Epilepsy Curr, 11, 21, 10.5698/1535-7511-11.1.21 · DOI
  45. RD Morin, 2008, Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells., Genome Res, 18, 610, 10.1101/gr.7179508 · DOI · Paper page
  46. JE Babiarz, 2011, A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing., RNA, 17, 1489, 10.1261/rna.2442211 · DOI
  47. I Bray, 2009, Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival., PLoS One, 4, e7850, 10.1371/journal.pone.0007850 · DOI
  48. SS Hebert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression., Proc Natl Acad Sci USA, 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
  49. DM Garcia, 2011, Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs., Nat Struct Mol Biol, 18, 1139, 10.1038/nsmb.2115 · DOI

Cited by

Sorted by citations

Metadata

Authors
McKiernan, R. C., Jimenez-Mateos, E. M., Bray, I., Engel, T., Brennan, G. P., Sano, T., Michalak, Z., Moran, C., Delanty, N., Farrell, M., O’Brien, D., Meller, R., Simon, R. P., Stallings, R. L., & Henshall, D. C.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2012-05-15
Volume
7
Issue
5
Pages
e35921
ISSN
1932-6203
DOI
10.1371/journal.pone.0035921
PMC
PMC3352899
Cited by
115
References
5
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review